CrushSCI.com
71.2平均天数
66.5中位天数
1最短天数
232最长天数
6862025发文量

Paper Review Records

全部论文审稿周期

16 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

1 天

A new era in anti-RAS therapy: Unique challenges and opportunities for radiotherapy clinical trials

作者
Susannah G. Ellsworth; Timothée Olivier展开收起
作者单位
Department of Radiation Oncology, University of Pittsburgh Hillman Cancer Center, Pittsburgh, PA, USA; Department of Medicine, University of Geneva (UNIGE), Geneva, Switzerland; Department of Oncology, Geneva University Hospital, Geneva, Switzerland展开收起
PDF源文件 DOI 网页
1 天

Outcomes of CD20-targeting CAR T-cell therapy in patients with advanced melanoma: MB-CART20.1 Melanoma phase I trial

作者
Hyatt Balke-Want; Sebastian Theurich; Philipp Gödel; Stefanie Biedermann; Nicole Kreuzberg; Peter Borchmann; Danmei Zhang; Lena Weiss; Klara Dorman; Veit Bücklein; Marion Subklewe; Dirk Tomsitz; Lucie Heinzerling; Florentine Pia Altefrohne; Christine Schubert; Linda Hanssens; Liang Gao; Anders Wennborg; Heinz Haverkamp; Michael Apel; Tatjana Holzer; Ben Novak; Max Schlaak; Hinrich Abken; Nadine Kutsch; Michael von Bergwelt-Baildon展开收起
作者单位
Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, University Hospital Cologne, Cologne, Germany; Cancer Center Cologne Essen (CCCE), Cologne, Germany; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany; Department of Medicine III, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Germany; Miltenyi Biotec, Bergisch Gladbach, Germany; Department of Dermatology and Venereology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany; Department of Dermatology and Allergology, LMU, Munich, Germany; Skin cancer center LMU, Munich, Germany; Miltenyi Biomedicine, Bergisch Gladbach, Germany; Department of Dermatology and Allergology, Vivantes Hospital Spandau, Berlin, Germany; Leibniz Institute for Immunotherapy, Div. Genetic Immunotherapy, and Chair Genetic Immunotherapy, University Hospital Regensburg, Germany展开收起
PDF源文件 DOI 网页
43 天

Diagnostic challenges in WHO classification of thymic epithelial tumors: The clinical value of an international expert pathology panel

作者
Marlou M. Dimmers; Daphne W. Dumoulin; Michael A. den Bakker; Anja C. Roden; Alexander Marx; Andre L. Moreira; Annika Weissferdt; Francien H. van Nederveen; Malgorzata Szolkowska; Nils A. ‘t Hart; Teodora Radonic; Thierry J. Molina; Wim Timens; Joachim G.J.V. Aerts; Jan H. von der Thüsen展开收起
作者单位
Department of Respiratory Medicine, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, the Netherlands; Department of Pathology, Maasstad Hospital, Rotterdam, the Netherlands; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA; Institute of Pathology, University Medical Center Göttingen, Göttingen, Germany; Department of Pathology, New York University Grossman School of Medicine, New York, USA; Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of Pathology, Laboratory of Pathology Dordrecht, Dordrecht, the Netherlands; Department of Pathology, The Institute of Tuberculosis and Lung Diseases, Warsaw, Poland; Department of Pathology, Isala, Zwolle, the Netherlands; Department of Pathology, Amsterdam University Medical Center & Cancer Center, Amsterdam, the Netherlands; Department of Pathology, Université Paris Cité, AP-HP, Hôpitaux Universitaires Robert Debré et Necker Enfants-Malades, France; Department of Pathology and Medical Biology, UMC Groningen, Groningen, the Netherlands; Department of Pathology and Clinical Bioinformatics, Erasmus MC, Rotterdam, the Netherlands展开收起
PDF源文件 DOI 网页
1 天

Acute and long-term outcomes of CD20-targeting CAR T-cell therapy in relapsed or refractory B-NHL: MB-CART20.1 Lymphoma phase I trial

作者
Nadine Kutsch; Hyatt Balke-Want; Stefanie Biedermann; Georg-Nikolaus Franke; Vladan Vučinić; Florentine Pia Altefrohne; Christine Schubert; Tobias Kampfenkel; Anders Wennborg; Heinz Haverkamp; Liang Gao; Tatjana Holzer; Ben Novak; Peter Borchmann; Philipp Gödel展开收起
作者单位
Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital Cologne, University of Cologne, Cologne, Germany; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany; Cancer Research Center Cologne Essen (CCCE), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany; Medizinische Klinik und Poliklinik I - Hämatologie und Zelltherapie, Hämostaseologie und Infektiologie, University Hospital Leipzig, Leipzig, Germany; Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany; Miltenyi Biomedicine GmbH, Bergisch Gladbach, Germany展开收起
PDF源文件 DOI 网页
68 天

Targeting IL-12 and IL-23 in immune-related adverse events from checkpoint inhibitors: current evidence and future directions

作者
Malek Shatila; David Farris; Pankti Reid; Thomas U. Marron; Sophia C. Weinmann; Alexa S. Meara; Yinghong Wang展开收起
作者单位
Division of Internal Medicine, Wayne State University/Detroit Medical Center, Detroit, MI, United States; Research Medical Library, The University of Texas MD Anderson Cancer Center, Houston, TX, United States; Division of Rheumatology, Committee on Clinical Pharmacology and Pharmacogenomics, University of Chicago Medical Center, Chicago, IL, United States; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, United States; Division of Rheumatology and Immunology, Duke University, Durham, NC, United States; Division of Rheumatology and Immunology, Ohio State University Wexner Medical Center, Columbus, OH, United States; Division of Gastroenterology and Hepatology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States展开收起
PDF源文件 DOI 网页
113 天

What does addressing cancer inequalities really mean? Five principles that can drive global action

作者
Matti Aapro; Nicolò Matteo Luca Battisti; Joseph Gligorov; Abiola Ibraheem; Dorothy Keefe; Stewart O’Callaghan; May Abdel-Wahab展开收起
作者单位
Sharing Progress in Cancer Care, Bellinzona, Switzerland; Multidisciplinary Oncology Institute, Genolier, Switzerland; The Royal Marsden NHS Foundation Trust, Sutton, UK; Institute of Cancer Research, London, UK; European Cancer Organisation, Brussels, Belgium; Institut Universitaire de Cancérologie AP-HP, Sorbonne Université, Hospital Tenon Ap-Hp, Mediterranean Association for Radiotherapy Oncology and Medical Oncology (AROME), Paris, France; University of Illinois, Chicago, United States; African Organisation for Research and Training in Cancer (AORTIC), Chicago, United States; Cancer Australia, Sydney, Australia; College of Health, Adelaide University, Adelaide, Australia; OUTpatients LGBTIQ+ cancer charity, London, United Kingdom; Division of Human Health, Department of Nuclear Applications, International Atomic Energy Agency (IAEA), Vienna, Austria展开收起
PDF源文件 DOI 网页

FAQ

EUROPEAN JOURNAL OF CANCER审稿要多久?

截至2026-11-19,CrushSCI 收录了 EUROPEAN JOURNAL OF CANCER 的 16 篇完整审稿记录。最快一篇从收稿到录用用了 1 天(A new era in anti-RAS therapy: Unique challenges and opportunities for radiotherapy clinical trials,2026-10-15 收稿,2026-10-16 录用),最慢一篇用了 232 天;平均 71.2 天,中位数 66.5 天。最快这篇的日期间隔异常短,建议点开原文核对。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。